Dolby Laboratories reported second quarter fiscal 2024 financial results, with total revenue of $364.5 million, a decrease from $375.9 million in the second quarter of fiscal 2023. GAAP net income increased to $97.8 million, or $1.01 per diluted share, compared to $95.7 million, or $0.98 per diluted share, for the same quarter last year. Non-GAAP net income also increased slightly to $123.2 million, or $1.27 per diluted share.
Total revenue was $364.5 million, a decrease from $375.9 million in the second quarter of fiscal 2023.
GAAP net income was $97.8 million, or $1.01 per diluted share, compared to $95.7 million, or $0.98 per diluted share, for the second quarter of fiscal 2023.
Non-GAAP net income was $123.2 million, or $1.27 per diluted share, compared to $122.6 million, or $1.26 per diluted share, for the second quarter of fiscal 2023.
Dolby repurchased 294 thousand shares of its common stock and ended the quarter with approximately $107 million of stock repurchase authorization available going forward.
Dolby provided estimates for the third quarter of fiscal year 2024. Total revenue is estimated to range from $270 million to $300 million. Diluted earnings per share is anticipated to range from $0.21 to $0.36 on a GAAP basis and from $0.51 to $0.66 on a non-GAAP basis.
Visualization of income flow from segment revenue to net income